Courts as policy actors: The blurring of punitiveness in Norwegian drug reform

In 2019, an expert committee in Norway proposed major drug policy reforms, including decriminalization. Although rejected, the proposals ignited unprecedented debate over the legitimacy and effectiveness of penal responses to drug use. This article examines how these debates reshaped judicial decision-making on minor drug offenses (2019-2022) and how these judicial practices influenced subsequent legislative reform in 2025. Drawing on 40 appellate rulings, the analysis shows how courts increasingly reduced or suspended punishment for drug-dependent individuals, invoking rehabilitation and proportionality. We conceptualize this as “blurring of punitiveness”: while drug use remained criminalized, courts have generated a form of partial depenalization and a normative shift toward health-oriented approaches. Crucially, by foregrounding rehabilitation-potential as a discretionary criterion, judges not only legitimize lenient outcomes but also reproduce stigma and unequal treatment by distinguishing whose drug use counted as punishable. In 2025, parliament codified important aspects of these judicial innovations, exempting drug-dependent individuals from punishment and removing personal use from criminal records, while leaving courts to determine who qualifies. Examining how judicial practice shapes drug policy reform, this analysis highlights courts as key policy actors. The study underscores how courts navigate tensions between punitive traditions, procedural justice, and evolving societal understandings of drug use.